Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diabetic Macular Edema
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 30 years and 80 years
- Gender
- Both males and females
Description
To investigate the efficacy of intravitreal ranibizumab injections compared to combination with Micropulse Laser in Chinese patients with visual impairment in DME. The result of the study will be used to support new therapy in DME patients in China.
To investigate the efficacy of intravitreal ranibizumab injections compared to combination with Micropulse Laser in Chinese patients with visual impairment in DME. The result of the study will be used to support new therapy in DME patients in China.
Tracking Information
- NCT #
- NCT03690947
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Xiaobing Yu, M.D. Beijing Hospital
Get Well Soon